Literature DB >> 24685533

Reproducibility of estradiol and testosterone levels in postmenopausal women over 5 years: results from the breakthrough generations study.

Michael E Jones, Minouk J Schoemaker, Megan Rae, Elizabeth J Folkerd, Mitch Dowsett, Alan Ashworth, Anthony J Swerdlow.   

Abstract

Prospective cohort studies examining sex hormones in relation to cancer risk have generally collected blood samples at 1 time point, with an assumption that hormone levels measured in these samples will be reliable markers of true levels at other times. In postmenopausal women, body fat is a major source of estradiol; therefore, changes in adiposity may affect the correlation of single measurements to more relevant long-term averages. To estimate the intraclass correlation coefficient (ICC) for estradiol and testosterone, we collected repeat blood samples from 119 postmenopausal women (average age = 59.4 (standard deviation, 4.7) years) from the United Kingdom during 2004-2005 and again during 2010-2011. The ICCs (adjusted for assay variation) were 0.73 (95% confidence interval: 0.63, 0.82) for total estradiol and 0.59 (95% confidence interval: 0.47, 0.72) for total testosterone. The ICCs were 3%-5% larger after adjustment for change in body mass index (weight (kg)/height (m)(2)) or leptin, which are 2 markers of change in adiposity. There was no increase in ICCs after adjustment for change in age, alcohol consumption, smoking, exercise, time between waking and blood collection, or season. The results suggest that other factors account for within-woman variation in these sex hormones.

Entities:  

Keywords:  estradiol; reproducibility of results; testosterone

Mesh:

Substances:

Year:  2014        PMID: 24685533     DOI: 10.1093/aje/kwu027

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  6 in total

1.  Addressing barriers to uptake of breast cancer chemoprevention for patients and providers.

Authors:  Katherine D Crew
Journal:  Am Soc Clin Oncol Educ Book       Date:  2015

2.  A Metabolomics Analysis of Body Mass Index and Postmenopausal Breast Cancer Risk.

Authors:  Steven C Moore; Mary C Playdon; Joshua N Sampson; Robert N Hoover; Britton Trabert; Charles E Matthews; Regina G Ziegler
Journal:  J Natl Cancer Inst       Date:  2018-06-01       Impact factor: 13.506

3.  Quantifying the Role of Circulating Unconjugated Estradiol in Mediating the Body Mass Index-Breast Cancer Association.

Authors:  Catherine Schairer; Barbara J Fuhrman; Jennifer Boyd-Morin; Jeanine M Genkinger; Mitchell H Gail; Robert N Hoover; Regina G Ziegler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-12-04       Impact factor: 4.254

4.  Plasma total testosterone and risk of incident atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Dylan Berger; Aaron R Folsom; Pamela J Schreiner; Lin Y Chen; Erin D Michos; Wesley T O'Neal; Elsayed Z Soliman; Alvaro Alonso
Journal:  Maturitas       Date:  2019-03-31       Impact factor: 4.342

Review 5.  Risk determination and prevention of breast cancer.

Authors:  Anthony Howell; Annie S Anderson; Robert B Clarke; Stephen W Duffy; D Gareth Evans; Montserat Garcia-Closas; Andy J Gescher; Timothy J Key; John M Saxton; Michelle N Harvie
Journal:  Breast Cancer Res       Date:  2014-09-28       Impact factor: 6.466

6.  Hormonal, metabolic and inflammatory circulating biomarker profiles in obese and non-obese Brazilian middle-aged women.

Authors:  Leonardo Victor Galvão-Moreira; Anna Cyntia Brandão Nascimento; Izabella Mikaella Souza Campos D'Albuquerque; Marcus Antonio Silva Sousa; Haissa Oliveira Brito; Maria do Desterro Soares Brandão Nascimento; Maria Bethânia da Costa Chein; Luciane Maria Oliveira Brito
Journal:  PLoS One       Date:  2019-09-11       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.